NAOE Tomoki | Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
スポンサーリンク
概要
- NAOE Tomokiの詳細を見る
- 同名の論文著者
- Department of Hematology and Oncology, Nagoya University Graduate School of Medicineの論文著者
関連著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
三木 義男
癌研ゲノムセンター
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
OHNO Ryuzo
Aichi Cancer Center
-
小嶋 哲人
Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital
-
小嶋 哲人
名古屋大学医学部第一内科
-
小嶋 哲人
名古屋大学 保健
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MATSUSHITA Tadashi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
KOJIMA Tetsuhito
Department of Medical Technology, Nagoya University School of Health Sciences
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Matsushita Tadashi
Department Of Pathophysiological Laboratory Sciences Nagoya University Graduate School Of Medicine
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
MEGURO KUNIAKI
National Sendai Hospital
-
ITO Masafumi
Department of Pathology, Japanese Red Cross Nagoya Daiichi Hospital
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
ISHIKAWA Yuichi
Department of Pathology, the Cancer Institute of JFCR
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
室 隆桂之
高輝度光科学研究センター
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
HIRAGA Junji
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Matsushita Toyoaki
Department Of Cardiology Nagoya University Graduate School Of Medicine
-
SAITO Hidehiko
Nagoya Central Hospital
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
Moriyama Toshiki
大阪大学 腎臓内科
-
Moriyama Toshiki
Health Care Center Osaka University
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Matsushita Toyoaki
Department Of Internal Medicine Aichi-gakuin School Of Dentistry
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Nakagawa Shun-ichi
鈴鹿中央総合病院(厚生連)
-
Shimoda Kazuya
九州大学 第1内科
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
SHIMADA Kazuyuki
Department of Medicine, Jichi Medical University
-
Tobinai Kensei
東海大学 医学部
-
OHNO Toshihito
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MORI Naoyoshi
Department of Pathology of Biological Response, Nagoya University Graduate School of Medicine
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TAKAGI Akira
Department of Medical Technology, Nagoya University School of Health Sciences
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
Yamamoto Koji
Department of Internal Medicine, Hattori Memorial Hospital
-
Murate Takashi
名古屋大学 医学研究科病態解析学分野
-
NARIMATSU Hiroto
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Matsushita Toyoaki
Department Of Cardiology Nagoya University Graduate Shool Of Medicine
-
Hatsumi Naoko
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
三木 義男
東京医歯大 難治疾患研 疾患医科学研究系分子遺伝分野
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
永井 正
自治医科大学内科学講座血液学部門
-
Suzuki Tatsuya
Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University
-
谷脇 雅文
高知工科大学工学部
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
HANAMURA Akitoshi
Department of Hematology, Gifu Prefectural Tajimi Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
Muramatsu Takashi
名古屋大学 循環器内科学
-
Murase Takuhei
Department Of Hematology Toyota Memorial Hospital
-
Murate Takashi
Department Of Medical Technology Nagoya University Graduate School Of Health Sciences
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
JINNAI Itsuro
Nagasaki CML Study Group
-
Mano Hiroyuki
Division of functional genomics, Jichi Medical University
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Kato Tomoyuki
愛知県がんセンター研究所 疫学予防部
-
KOJIMA Seiji
Department of Pediatrics, Nagoya University Graduate School of Medicine
-
TAKAMATSU Junki
Department of Transfusion Medicine, Cardiology and Hematology, Nagoya University Hospital
-
MORI Yumiko
Department of Biotechnology, Graduate School of Engineering, Osaka University
-
UEDA Ryuzo
Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sci
-
MUROHARA Toyoaki
Department of Cardiology, Nagoya University Graduate School of Medicine
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
KANEGANE Hirokazu
Department of Pediatrics, Graduate School of Medicine, University of Toyama
-
MIYAWAKI Toshio
Department of Pediatrics, Graduate School of Medicine, University of Toyama
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
ITO Etsuro
Department of Pediatrics, Hirosaki University School of Medicine
-
UEDA Takanori
First Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
Muramatsu Toshiya
behalf of the j-Cypher Registry Investigators
-
NAKAYAMA Takayuki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Watanabe Takashi
Department of Chemistry, Graduate School of Science, Kyoto University
-
松井 太衛
藤田保健衛生大学衛生学部生物学
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
MURATE Takashi
Nagoya University School of Health Sciences
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
松井 太衛
藤田保健衛生大
-
Nomura Keiko
Department of Pediatrics, Toyama University School of Medicine
-
Yamada Osamu
Division of Pediatrics, National Cardiovascular Center
-
Takagi K
Department Of Medical Technology Nagoya University School Of Health Sciences
-
OHASHI Haruhiko
Department of Clinical Research, Nagoya National Hospital
-
SUGISAKI Chiho
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
LI Eika
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
ASANO Haruhiko
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
ITO Tatsuya
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAGAI Hirokazu
Department of Clinical Research, Nagoya National Hospital
-
YAMASHITA Yoriko
Department of Pathology of Biological Response, Nagoya University Graduate School of Medicine
-
FUKAMI Shouko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
NODA Atsuhiko
Department of Hematology, Tajimi Prefectural Hospital
-
ICHIKAWA Atsushi
Department of Hematology, Tajimi Prefectural Hospital
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
SHINTANI Satoshi
Department of Cardiology, Nagoya University Graduate School of Medicine
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Ishizawa Shin
2nd Department Of Pathology Graduate School Of Medicine University Of Toyama
-
TOKI Tsutomu
Department of Pediatrics, Hirosaki University School of Medicine
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
Hasegawa Takuya
Department of Cardiology, National Cardiovascular Center
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Ueda Ryuzou
Second Department Of Medicine Nagoya City University Medical School
-
Mano Akiko
Department Of Organ Transplantation National Cardiovascular Center
-
SONTA Shin-ichi
Department of Genetics, Institute for Developmental Research
-
ASAI Osamu
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
KOJIMA Hiroshi
Department of Hematology, Institute of Clinical Medicine, University of Tsukuba
-
HAMAJIMA Nobuyuki
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Gradu
-
Yokota M
Department Of Genome Science School Of Dentistry Aichi-gakuin University
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
HATA Tomoko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
NISHIDA Tetsuya
Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital
-
IINO Shiro
Kiyokawa Hospital
-
YOSHIBA Fumiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
KASAI Masanobu
Department of Hematology, Nagoya Daini Red Cross Hospital
-
KUBO Kohmei
Department of Hematology, Aomori Prefectural Central Hospital
-
Nomura Keiko
Department Of Pediatrics Graduate School Of Medicine University Of Toyama
-
Kanegane Hirokazu
富山大学 医学薬学研究部小児科学教室
-
Kanegane Hirokazu
防衛医科大学校 小児科学
-
Kanegane Hirokazu
Department Of Pediatrics Faculty Of Medicine University Of Toyama
-
TANIWAKI Masafumi
Department of Environmental Systems Engineering, Kochi University of Technology
-
Izawa Hideo
Department of Cardiology, Fujita Health University, Banbuntane Hotokukai Hospital
-
Ito Tatsuya
Department Of Cardiology Toyohashi Heart Center
-
FUJITA Hiroyuki
Department of Rheumatology/Hematology/Infectious Disease, Yokohama City University Hospital
-
Harada Mine
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Harada M
Department Of Hematology-oncology Ehime Prefectural Central Hospital
-
Harada Mine
岡山大学 第2内科
-
Tomonari Akira
東京大学医科学研究所附属病院 血液腫瘍内科
-
Tomonari Akira
Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo
-
Tomonari Akira
Department Of Hematology/oncology
-
Komatsu Hirokazu
名古屋市立大学 医学研究科腫瘍･免疫内科学
-
Matsue Kosei
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
FUJIMURA Yoshihiro
Department of Blood Transfusion Medicine, Nara Medical University
-
OMOTO Eijiro
Second Department of Medicine, Okayama University Medical School
-
Kanegane Hirokazu
富山大学 医学薬学研究部小児発達医学
-
Kanegane H
Department Of Pediatrics Graduate School Of Medicine University Of Toyama
-
Akashi Koichi
九州大学 医学研究院病態修復内科学
著作論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue